Blood Transfusion Diagnostics Market by Product (Instrument and Kits, Reagents, and Others), by Application (Blood Grouping and Disease Screening), and by End-User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 - 2029

                                          
Abstract
                    
The report covers forecast and analysis for the blood transfusion diagnostics market on a global and regional level. The study provides historic data for 2015, 2016, 2017 along with a forecast from 2018 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the blood transfusion diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the blood transfusion diagnostics market on a global level.

In order to give the users of this report a comprehensive view on the blood transfusion diagnostics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a customer and region segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.

The study provides a decisive view on the blood transfusion diagnostics market by segmenting the market based on customer and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

On the basis of product type, global blood transfusion diagnostics market is divided into kits and reagents, filtration systems, services, and others. Among these kits and reagents segment was the highest revenue grosser in 2017. On the basis of application, the market is divided into blood grouping and disease screening. The end-user segment includes hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood banks and hospitals dominated the market and accounted for the largest share in 2017.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries including the U.S. Germany, France, the UK, China, Japan, India, and Brazil. This segmentation includes demand for blood transfusion diagnostics based on individual segment and applications in all the regions and countries.

Some of the key players in blood transfusion diagnostics market include BAG Health Care GmbH, Grifols, S.A., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, DiaSorin S.p.A., Immucor, Inc., Quotient Limited, Hologic, Inc. and Ortho Clinical Diagnostics.

This report segments the global blood transfusion diagnostics market as follows:

Global Blood Transfusion Diagnostics Market: Product Type Segment Analysis

	Instruments and Kits
	Reagents
	Others

Global Blood Transfusion Diagnostics Market: Application Segment Analysis

	Blood Grouping
	Disease Screening

Global Blood Transfusion Diagnostics Market: End-user Segment Analysis

	Hospitals
	Diagnostic Laboratories
	Blood Banks
	Plasma Fractionation Companies

Global Blood Transfusion Diagnostics Market: Regional Segment Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa